Breaking News on Pharmaceutical Technology

Product innovations > White / Technical Paper

Fill form to download now!

*
*
*
*
*
*
*
*
*

YesNo

Please note that any information that you supply is protected by our Privacy Policy.
Access to all documents and request for further information are available to all users at no cost. In order to provide you with this free service, William Reed Business Media SAS does share your information with companies that have content on this site. When you access a document or request further information from this site, your information may be shared with the owners of that document or information.

Handling Protocols Key Consideration in HPAPI Market

Published:18-Sep-2009
Format:PDF file
Type:White / Technical Paper

Over the past 10 years, the manufacture of highly potent active pharmaceutical ingredients (HPAPIs) has become increasingly attractive to contract manufacturers due to significant advances in clinical pharmacology and oncology research. In addition, with factors such as fewer FDA drug approvals, over-supply and stiff competition from Asia-Pacific producers putting pressure on profitability and margins in the ‘traditional’ API sector, the rapidly growing HPAPI segment has an annual double digit growth rate, has become something of a ‘promised land’ for CMOs.